Dr. Wertheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
6 Founders
Philadelphia, PA 19104Phone+1 215-662-6503
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematopathology, 2009 - 2011
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2005 - 2009
- Perelman School of Medicine at the University of PennsylvaniaClass of 2005
Certifications & Licensure
- NJ State Medical License 2019 - 2025
- PA State Medical License 2005 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 714 citationsIdentification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic LeukemiaDavid T. Teachey, Simon F. Lacey, Pamela A. Shaw, J. Joseph Melenhorst, Shannon L. Maude
Cancer Discovery. 2016-06-01 - 167 citationsA novel doxycycline-inducible system for the transgenic analysis of mammary gland biologyEdward J. Gunther, George K. Belka, Gerald Wertheim, James Y. Wang, Jennifer L. Hartman
FASEB Journal. 2002-03-01 - 191 citationsPersistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, James Capobianchi, Colleen Callahan
Blood. 2016-07-21
Abstracts/Posters
- DYRK1A Is Regulated By Oncogenic KMT2A and Required for Survival of KMT2A-Rearranged Acute Lymphoblastic LeukemiaGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Lncrna Morrbid Regulates Myeloid Cell Survival of AML Driven By a Combination of FLT3ITD and Epigenetic MutationsGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Oncogene-Independent Adaptation of Pre-B Cell Receptor Signaling Confers Drug Resistance and Signaling Plasticity in Ph-like ALLGerald Wertheim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: